BeyondSpring (BYSI) Retained Earnings (2015 - 2026)
BeyondSpring's (BYSI) quarterly Retained Earnings came in at -$411.4 million in Q2 2026, down 1.65% year-over-year from -$418.3 million in Q2 2025, and little changed quarter-over-quarter from -$410.6 million in Q1 2026.
Analysis
BeyondSpring (BYSI) Retained Earnings (2015 - 2026) Analysis & Trends
BeyondSpring has disclosed Retained Earnings across 12 years of filings, most recently posting -$411.4 million for Q2 2026.
- In Q2 2026, Retained Earnings fell 1.65% year-over-year to -$411.4 million; the TTM figure through Jun 2026 stood at -$411.4 million (down 1.65% YoY), while the FY2025 annual figure was -$408.4 million, changed 0.25% from the prior year.
- Retained Earnings came in at -$411.4 million for Q2 2026 at BeyondSpring, roughly flat from -$410.6 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $368.5 million in Q2 2022 to a low of -$411.4 million in Q2 2026.
- Average Retained Earnings over 5 years is -$337.2 million, with a median of -$404.2 million recorded in 2024.
- Year-over-year, Retained Earnings sank 71654.49% in 2022 and dropped 0.25% in 2025.
- Over 5 years, Retained Earnings stood at -$375.3 million in 2022, then retreated by 5.6% to -$396.3 million in 2023, then retreated by 2.81% to -$407.4 million in 2024, then declined by 0.25% to -$408.4 million in 2025, then slipped by 0.74% to -$411.4 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$411.4 million in Q2 2026, -$410.6 million in Q1 2026, and -$408.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 112.09 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | -4.00 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 1.10 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 9.16 Bn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | -411.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -411.44 Mn |
| Mar 31, 2026 | -410.59 Mn |
| Dec 31, 2025 | -408.43 Mn |
| Sep 30, 2025 | -406.29 Mn |
| Jun 30, 2025 | -404.75 Mn |
| Mar 31, 2025 | -402.95 Mn |
| Dec 31, 2024 | -407.43 Mn |
| Jun 30, 2024 | -403.56 Mn |
| Dec 31, 2023 | -396.30 Mn |
| Jun 30, 2023 | -388.00 Mn |
| Dec 31, 2022 | -375.28 Mn |
| Jun 30, 2022 | 368.47 Mn |
| Dec 31, 2021 | -523,000.00 |
| Sep 30, 2021 | 371.21 Mn |
| Jun 30, 2021 | 369.78 Mn |
| Mar 31, 2021 | 367.56 Mn |
| Dec 31, 2020 | -297,000.00 |
| Sep 30, 2020 | 284.31 Mn |
| Jun 30, 2020 | 277.62 Mn |
| Mar 31, 2020 | 250.42 Mn |